OMX30 1 548 -0,3%  OMXH25 3 919 0,2%  OMXC20 1 007 -0,1%  Dow 22 025 0,1%  Nas 5 917 0,2%  EUR 9,4874 -0,2%  USD 8,0784 0,0%  Olja 50,4 0,0%  Guld 1 288 0,4% 

Pfizer Aktie

269,00SEK -1,50SEK -0,55%
<
Bolag
Terminer
Profil
>
<
Relaterade värdepapper
ETP:er
Obligationer
>

Fundamentala nyckeltal för Pfizer

2016 2017e 2018e 2019e 2020e
Utdelning 1,20 1,28 1,36 1,42 1,51
Direktavkastning (i %) 3,69 3,83 4,05 4,25 4,51
PE-tal 13,54 13,06 12,16 11,77 11,12
Resultat/aktie 2,40 2,56 2,75 2,84 3,01
ytterligare nyheter

Analyser om Pfizer Inc.

Aug, 15 2017 Pfizer Hold Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
Aug, 02 2017 Pfizer Hold Jefferies & Company Inc.
Aug, 01 2017 Pfizer Hold Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
Jul, 20 2017 Pfizer Neutral Credit Suisse Group
Jul, 17 2017 Pfizer Outperform Bernstein Research
ytterligare analyser

Pfizer Peer Group

Abbott Laboratories 49,82
2,0%
Alexion Pharmaceuticals 136,51
0,9%
Allergan 0,00
0,0%
AstraZeneca 474,00
0,3%
Bayer 108,20
0,1%
Celgene 131,26
-0,1%
EVOTEC 15,38
2,6%
Gilead Sciences 73,38
0,3%
GlaxoSmithKline 15,07
0,2%
Johnson & Johnson 134,14
0,5%
Merck 62,70
0,3%
Merck 92,94
-0,3%
MorphoSys 56,90
0,0%
Mylan 30,47
1,1%
Novartis 81,40
-0,7%
Perrigo Company 0,00
0,0%
Pfizer 33,36
-0,1%
Roche 246,40
-0,4%
STADA 64,78
0,4%
Sanofi 82,68
0,1%
Teva Pharmaceutical Industries 17,48
-2,7%
Vertex Pharmaceuticals 151,35
-0,9%
Warner Chilcott 0,00
0,0%
pagehit

Lägg till instrument

Vad tycker du?

Profil Pfizer Inc.till bolagsprofilen

Pfizer, Inc. is a research-based, global biopharmaceutical company, which engages in the manufacture of vaccines and injectable biologic medicines. It operates through the following business segments: Global Innovative Pharmaceutical, Global Vaccines, Oncology and Consumer Healthcare, and Global Established Pharmaceutical. The Global Innovative Pharmaceutical segment focuses on developing, registering and commercializing novel, value creating medicines that significantly improve patients lives. The Global Vaccines, Oncology and Consumer Healthcare segment engages in the development and commercialization of vaccines and products for oncology and consumer healthcare. The Global Established Pharmaceutical segment includes the brands that have lost market exclusivity and, generally, the mature, patent-protected products that are expected to lose exclusivity through 2015 in most major markets and, to a much smaller extent, generic pharmaceuticals. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Realtidskurs Pfizer Inc.

Bid 33,36 USD Ask 36,00 USD
Kurstid 21:59 Börsen BTT

Aktiekurs Pfizer Inc. i SEKPUSH CHART

Kurs 269,00 SEK -1,50 -0,55 %
Kurstid 09:20:19
Datum 17.08.2017
Öppning 270,00
Gårdagen 270,50
Dagshögsta 270,00
Dagslägsta 269,00
52 v. högsta 316,00
52 v. lägsta 261,50
52 v. perf.
Volym (Antal) 228
Börsvärde (SEK) 1 613,38 Mrd
Börsen

Till aktien Pfizer

Ticker PFE
ISIN US7170811035
Index S&P 500, S&P 100, Dow Jones, NYSE US 100, BX Swiss - USA

Struktuerarde produkter på Pfizer

Produkttyp Antal
Mini Futures 3
Bull-Bear 2

Pfizer Nyckeltal

Börsvärde i SEK 1 613,38 Mrd
Free float % 99,94
Antal aktier mio. 5 947,35
Cashflow/aktie i lokal valuta 2,13
Bokvärde/aktie i lokal valuta 9,67
60 dagar vola 15,74
PBV 3,36

Pfizer Historiska kurser

2017-08-16 270,50 1 146
2017-08-15 270,00 1 078
2017-08-14 269,00 637
2017-08-11 273,50 941
2017-08-10 272,00 1 163